Vaxart, Inc. (VXRT) Financials

VXRT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 180.1 million 85.9 million
Dec. 31, 2025 186.1 million 98.3 million
Sept. 30, 2025 209.0 million 182.2 million
June 30, 2025 164.1 million 131.2 million

VXRT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -2.5 million 1.5 million
Dec. 31, 2025 30.7 million 1.7 million
Sept. 30, 2025 2.5 million 2.0 million
June 30, 2025 -15.8 million 2.1 million

VXRT Net Income

No data available :(

VXRT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 61.0 million 5.4 million -
Dec. 31, 2025 63.8 million - 9.0 million
Sept. 30, 2025 28.8 million - 15.4 million
June 30, 2025 26.3 million - 16.1 million

VXRT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 242.2 million
Dec. 31, 2025 230.3 million
Sept. 30, 2025 228.9 million
June 30, 2025 228.4 million

VXRT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 448000 29.4 million 4.6 million -
Dec. 31, 2025 1000 45.2 million 3.7 million -
Sept. 30, 2025 117000 75.9 million 4.3 million -
June 30, 2025 103000 49.7 million 4.6 million -

VXRT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 39.2 million -
Dec. 31, 2025 104.2 million 22.8 million
Sept. 30, 2025 72.4 million -
June 30, 2025 39.7 million -

VXRT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VXRT

Price: $0.60

52 week price:
0.26
0.84

Earnings Per Share: 0.16 USD

P/E Ratio: 4.31

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -2.9 million

Market Capitalization: 167.0 million

Links: